Recombinant Human ACKR2

Contáctenos para saber el precio
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Recombinant Human ACKR2
category
Proteins and Peptides
provider
FineTest
reference
P2105
tested applications
Western Blot, ELISA
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Proteins and Peptides |
Immunogen Target | 315-384 |
Host | E.Coli |
Origin | Human |
Observed MW | 28.3 kDa |
Expression | Recombinant |
Purity | Greater than 75% by SDS-PAGE gel analyses |
Purification | IF2DI tag |
Size 1 | 50μg |
Size 2 | 200μg |
Size 3 | 1mg |
Form | Lyophilized from a 0.2um filtered solution in PBS with 5% trehalose, pH7.4 |
Tested Applications | Western Blot, ELISA |
Buffer | Reconstitute with Sterile distilled water |
Availability | 7 days |
Storage | -20°C for 12 months as lyophilized;2-8°C for 1 month under sterile conditions after reconstitution |
UniProt ID | O00590 |
Alias | CCBP2,CCR10,CCR9,CMKBR9,D6 |
Background | Proteins ACKR2 |
Status | RUO |
Note | This product is for research use only. |
ACKR2 is a non-classical chemokine receptor that functions as a decoy and scavenger receptor, specifically binding pro-inflammatory CC chemokines to modulate immune responses and resolve inflammation. Unlike signaling chemokine receptors, ACKR2 does not trigger intracellular signaling but instead internalizes and degrades its ligands, reducing chemokine availability and dampening inflammation. It is primarily expressed on lymphatic endothelial cells and plays a critical role in maintaining immune homeostasis by clearing chemokines from tissues and promoting the resolution of inflammation. ACKR2 is also involved in shaping chemokine gradients, ensuring proper immune cell trafficking and preventing chronic inflammatory conditions. Dysregulation of ACKR2 has been linked to autoimmune diseases, chronic inflammation, and cancer, where its altered expression may contribute to pathological immune cell infiltration and tumor progression. Its scavenging activity and role in regulating immune responses make ACKR2 a potential therapeutic target for inflammatory and immune-related diseases.
Related Products

Recombinant Human ACKR2
Ver Producto
Atypical Chemokine Receptor 2 (ACKR2) Antibody
Rabbit polyclonal antibody against CCBP2 protein. Immunogen region is C-terminal.
Ver Producto
Atypical Chemokine Receptor 2 (ACKR2) Antibody
CCBP2 Antibody is a Rabbit Polyclonal antibody against CCBP2.
Ver Producto